Ursodiol for Veterinary Use
by Barbara Forney, VMD
Ursodiol, also known as ursodeoxycholic acid, is a hydrophilic bile acid that has been used successfully in treatment of cholestatic liver diseases of humans including chronic hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, intrahepatic cholestasis of pregnancy, non-alcoholic fatty liver disease, TPN induced cholestasis, some pediatric cholestatic liver diseases and graft/host liver transplant reactions.
Ursodiol has a number of hepatoprotective properties including immunomodulatory, cytoprotective and membrane stabilizing effects on hepatic cells. It expands the bile acid pool by increasing flow and displaces hepatotoxic, hydrophobic bile acids. It suppresses the synthesis, secretion and intestinal absorption of cholesterol. Ursodiol is well-absorbed through oral administration.
Dogs and Cats
Ursodiol is now used in a variety hepatobiliary conditions in small animals. Its use is better established in dogs although it also has been reported on in cats. In dogs, ursodiol is used in chronic hepatitis, some forms of acute hepatic failure or toxic injury, some congenital abnormalities including primary portal vein hypoplasia and juvenile fibrosing liver disease.
There is less information on its ursodiol in cats, but it may be used in cases of chronic hepatitis and congenital portosystemic shunts.
Ursodiol should be given with food. Efficacy may be monitored by using liver enzymes, ultrasound or other liver function tests.
Ursodiol Side Effects
Ursodiol generally is well tolerated. Vomiting and diarrhea rarely occur. Side effects in humans include diarrhea and other GI symptoms.
- Ursodiol may be contraindicated in patients with biliary obstruction, fistula and other complications associated with gallstones or pancreatitis.
- Some patients with chronic liver disease may have increased difficulty with bile acid metabolism.
- Ursodiol should not be used in rabbits or other hind gut fermenters.
- Ursodiol has been investigated in pregnant women with intrahepatic cholestasis of pregnancy and has been found to improve fetal prognosis. Similar work has not been done in animals. It is not known if ursodiol is excreted in breast milk.
Concurrent antacid use may decrease the effectiveness of ursodiol.
The most likely occurrence with overdose is an increase in severity of GI signs, particularly diarrhea. Gastric emptying, activated charcoal and oral administration of an aluminum containing antacid may be indicated.
About the Author
Dr. Barbara Forney is a veterinary practitioner in Chester County, Pennsylvania. She has a master's degree in animal science from the University of Delaware and graduated from the University of Pennsylvania School of Veterinary Medicine in 1982.
She began to develop her interest in client education and medical writing in 1997. Recent publications include portions of The Pill Book Guide to Medication for Your Dog and Cat, and most recently Understanding Equine Medications published by the Bloodhorse.
Dr. Forney is an FEI veterinarian and an active member of the AAEP, AVMA, and AMWA.
You can purchase books by Dr. Forney at www.exclusivelyequine.com The information contained on this site is general in nature and is intended for use as an informational aid. It does not cover all possible uses, actions, precautions, side effects, or interactions of the products shown, nor is the information intended as medical advice or diagnosis for individual health problems or for making an evaluation as to the risks and benefits of using a particular product. You should consult your doctor about diagnosis and treatment of any health problems. Information and statements have not been evaluated by the Food and Drug Administration ("FDA"), nor has the FDA approved the products to diagnose, cure or prevent disease.
Wedgewood Pharmacy compounded veterinary preparations are not intended for use in food and food-producing animals.